Trump's second term has included pauses to HIV public awareness campaigns and the cancellation of at least 20 grants funding ...

Prospective cuts to domestic HIV prevention efforts at the Centers for Disease Control and Prevention could widen health disparities and weigh heaviest on young Black and Hispanic men in the South, ...

In HIV-positive MSM, pain severity was significantly associated with pain management experiences and unhealthy alcohol use.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

In his first term, President Donald Trump launched a bold and successful initiative against HIV. This time around, the ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

The CDC budget cuts could pose headwinds for HIV drugmakers like Gilead and Merck but are unlikely to severely cripple their ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Disparities in HIV diagnosis rates were observed between Black and White individuals in the US from 2017 to 2021.

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...